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Background: Probe-based confocal laser endomicroscopy is a novel imaging tool in the field of
respiratory medicine. It enables a real-time and bedside qualitative characterization at the
level of small airways but due to a relatively small field of view the reliability of quantification
remains uncertain.
Methods: Twenty-six lung transplant recipients were subjected to two consecutive alveolo-
scopic imaging procedures within a median time interval of 90 days to analyze testeretest reli-
ability. Only patients in a stable clinical condition were analyzed. We studied alveolar duct
diameter, elastic fiber thickness at the alveolar level, the number of autofluorescent cells
at the level of the alveolar space, the diameter of autofluorescent alveolar cells and their
autofluorescence intensity.
Results: Intraclass correlation coefficients ranged from 0.56 for elastic fiber thickness, 0.62 for
alveolar duct diameter, 0.29 for alveolar cell diameter, 0.74 for cellularity to 0.78 for alveolar
cell autofluorescence.
Conclusion: Probe-based confocal laser endomicroscopy enables imaging and quantitative
measurements at the level of small airways and alveolar ducts. Testeretest reliability is good
for cellularity and autofluorescence quantification but only moderate for morphometric anal-
ysis of elastic fibers and alveolar ducts.
ª 2013 Elsevier Ltd. All rights reserved.Division, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Tel.: þ32 16 34 68 01;
euven.be (J. Yserbyt).
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A novel imaging tool was recently developed to enable phy-
sicians to obtain three dimensional and ‘in vivo’ images of the
pulmonary acinus. Probe-based confocal laser endomicro-
scopy (pCLE) uses a thin semi-flexible probe that can be
advanced through the human airways by inserting it in the
working channel of a flexible bronchoscope. In 2009, the first
data about its application for the visualization of alveolar
ducts were published.1 Real-time in vivo endomicroscopic
imaging of alveolar ducts became possible, based upon the
autofluorescence characteristics of elastic fibers present
throughout the tracheobronchial tree2 and in the pulmonary
acinus.1 Whenever present, autofluorescent cells situated in
the alveolar spaces can also be visualized.3 Although the po-
tential for ‘virtual biopsy’ through pCLE imaging is appealing,
its purpose in respiratory medicine today is merely pre-
clinical. The interobserver agreement for in vivo pCLE imag-
ing has been described previously and seemed good for auto-
fluorescence brightness of both central airways and alveoli,
fair for elastic fiber thickness, and good for alveolar cellu-
larity. Intraobserver and intrapatient agreement, on the other
hand, was excellent.4 However, this analysis was only based
upon a qualitative assessment. There have been attempts to
quantify pCLE findings,5 but these studies were performed in
murine and pig models, in which pCLE imaging is performed
through a thoracic window at the surface of the lung. Human
imaging is performed through a flexible bronchoscope in a
spontaneously breathing and only moderately sedated pa-
tient, resulting in totally different imaging characteristics.
Although high observer agreement is desirable, this is
not sufficient to assure test data consistency. The assess-
ment of testeretest reliability for this new technique is as
important. The current project focused on recruitment
among patients needing regular bronchoscopic assess-
ments. Testeretest reliability was therefore assessed in
lung transplant recipients in stable clinical condition, being
referred for two consecutive bronchoscopies within a
limited time interval.
Material and methods
Study design
From January 2011 until June 2012, 100 patients were
enrolled to be subjected to probe-based confocal laser
endomicroscopy at the time of their referral for one or
more bronchoscopic procedures.
The subjects were all lung transplant recipients referred
for surveillance bronchoscopy during follow-up after lung
transplantation. All subjects underwent a standardized
flexible bronchoscopy as stated by the internal protocol for
heart and lung transplantation consisting of a surveillance
broncho-alveolar lavage of 100 ml and endobronchial bi-
opsies. Transbronchial lung biopsies were obtained when
their indication was reported by the referring physician.
This study was conducted in accordance with the amended
Declaration of Helsinki. The Ethics Committee of the Uni-
versity Hospital Leuven (Leuven, Belgium, reference
ML6736/registration S52548) approved the protocol, and
written informed consent was obtained from all patients.Patient selection
Since we assumed that test variables could be influenced by
any change in pulmonary status of the studied patient, only
patients judged to be in ‘a stable clinical condition’ were
taken into account for statistical analysis. Patients were
considered to be in ‘a stable clinical condition’ when no evi-
dence for active pulmonary disease was found based upon
clinical findings: absence of respiratory symptoms, normal
lung auscultation, absence of oxygen supplementation, no
fever, no coughing; a decrease in Forced Expiratory Volume in
1 s (FEV1) of less than 5% during the last 6 months; normal
chest X ray, absence of pulmonary consolidation or tree-in-
bud on chest CT scan; absence of biochemical signs of active
inflammation. As a result of this, patients with clinical indi-
cation of underlying infection or rejection prior to the first
bronchoscopic evaluation, were excluded from the analysis.
Methods
The imaging technique currently under study, named pCLE
makes use of a thin semi-flexible probe with a diameter of
1.4mm,which canbeadvanced through thehumanairways by
inserting it in the working channel of a bronchoscope. This
probe consists of 30,000 small optical fibers, guiding a laser
beam onto the surface of the bronchial wall or into the alve-
olar space, generating real timemoving imageswith anoptical
area of 0.28 mm2 at a video frame rate of 12 images per sec-
ond.1 Based upon the physical principal of autofluorescence,
components of the respiratory tissue generating a fluorescent
signal at the given excitation wave length (488 nm), can be
visualized. The lateral resolution of the device is 3 mm,
meaning that 2 points at a distance of at least 3 mm can be
discriminated by the human eye as separate points, allowing
imagingat apotential cellular level.Theoptical plane inwhich
confocal imaging is performed, is characterized by a fixed
depth of focus of 50mm,making it possible toengage inwhat is
referred to as ‘three dimensional endomicroscopy’.
In all patients the alveoloscopic imaging was performed in
a standardized manner. The probe was consecutively intro-
duced into the anterior, lateral and posterior subsegments of
one of the transplanted lower lobes and further into the
posterior subsegments of the ipsilateral upper lobe. In each
subsegment, the probe was gently pushed forward to reach
the subpleural space. The images generated were recorded
to allow post-procedural measurements. For every segment
the recorded video was analyzed frame-by-frame. Measure-
ments were performed on every intact alveolar duct opening
and every alveolar cell. Since statistical analysis of upper and
lower lobes separately did not result in different values for
ICC, we only describe the findings for both lobes together.
Aminimumof4 subsegmentsperprocedurewereanalyzed,
but according to procedural time and patient tolerance
additional subsegments were visualized. All procedures were
performed by the same endoscopist, using the same bron-
choscope (Olympus BP type 1T160).
Analysis
Using a software package (Cellvizio Viewer 1.4 R, Mauna
Kea, Paris, France) a postprocedural morphometric analysis
was performed on the acquired endomicroscopic images. In
1236 J. Yserbyt et al.every patient the following variables were measured:
alveolar duct diameter in micrometer (1 longest internal
diameter or ‘long axis’ and 1 perpendicular longest internal
diameter or ‘short axis’ per alveolar duct), thickness of
elastic fibers at alveolar openings situated at the level of
the alveolar duct in micrometer (referred to as ‘septal wall
thickness’ or SWT expressed as the mean thickness of 8
measurements per alveolar opening), the number of auto-
fluorescent cells at the level of the alveolar space (‘ACA
count’ expressed as number of cells per microscopic field),
diameter of autofluorescent cells at the level of the alve-
olar space (‘ACA diameter’ expressed in micrometer) and
the autofluorescence intensity of these cells (‘ACA AF’
expressed in units) (Fig. 1).
Statistical analysis
Results are expressed as mean  SD (standard deviation),
unless otherwise indicated. Descriptive statistics were
calculated for the different characteristics of all in-
dividuals. To assess the distribution of variables the
D’AgostinoePearson omnibus normality test was used. The
relationship between variables with Gaussian distribution in
each of the 2 procedures was calculated by use of the
Pearson correlation coefficient. Correlation for non-
parametric variables was tested using the Spearman’s
rank correlation coefficient. For an expected reliability of
0.85 and a minimal reliability of 0.70 with 95% power, the
sample size was calculated to a minimum of 23 subjects.
To determine the testeretest reliability the following
statistical methods were applied6: 1) Agreement between
measurements was assessed with the intraclass correlation
coefficients (single measures ICC2.1 using a two way randomFigure 1 Alveoloscopic image showing a ring built out of elastic
fibers at the level of an alveolar opening into an alveolar duct
(transversal plane). The measurements for the longest internal
diameter or ‘long axis’ (yellow line), the perpendicular longest
internal diameter or ‘short axis’ (green line), the elastic fiber
thickness (blue line), the diameter of alveolar cells (red line) and
the autofluorescence of alveolar cells (pink line) are shown. (For
interpretationof the references to colour in this figure legend, the
reader is referred to the web version of this article.)effects model with an absolute agreement definition); 2) the
mean difference between the test sessions ðdÞ together with
the 95% confidence intervals for d (95% CI); 3) Measurement
errors were assessed by the standard error of measurement,
SEM, and the SEM% of the mean. SEM was calculated using
the following formula: SEMZSD ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 ICCÞp ; 4) Blande
Altman graphs were plotted to give a visual interpretation of
the data as well as to determine reproducibility bias.
A significance level < 0.05 was considered statistically
significant. Statistical calculations were performed using
either Graphpad Prism 5 (GraphPad Software Inc., La Jolla,
USA) or the SPSS 19 Software for Windows (SPSS Inc., Chi-
cago, USA).
Results
Patient characteristics
From January 1st 2011 until June 1st 2012, 100 lung trans-
plant recipients were subjected to pCLE imaging, of whom 44
patients underwent more than one procedure. Out of these
44 patients, 9 were referred for bronchoscopy based on
clinical evidence of either infection or rejection and were
considered in no stable clinical condition and therefore
excluded for data analysis. 35 patients were found to be
eligible based on clinical grounds. Out of these 35 patients,
another 9 patients were excluded because of posthoc rea-
sons (4 showed acute rejection on transbronchial biopsy
after either the first or the second bronchoscopy, 1 patient
developed post-transplant lympho-proliferative disorder
during the time interval between two procedures, in 4 pa-
tients measurements were lacking in either one or both
procedures because of poor image quality). Fig. 2 shows a
flowchart representing the patient selection procedure.
Based upon data collected in the remaining 26 patients
(52 pCLE procedures) considered and proven as clinically
stable, testeretest reliability was calculated (Table 1 and
Fig. 3). Intervals between the consecutive pCLE procedures
taken into account were 20 days (1 patient, 3.8%), 40e100
days (19 patients, 73%), 140e180 days (5 patients, 19%) and
280 days (1 patient, 3.8%). In 92% of patients the interval
between the two consecutive procedures was less than 180
days (Histogram presented in Fig. 4).
Morphometric analysis
Measurements for the long axis of the alveolar duct diam-
eter (LA), short axis of the alveolar duct (SA), septal wall
thickness of the alveolar duct diameter (SWT), diameter of
the alveolar cells (ACAD) and autofluorescence intensity
(ACA AF) showed a Gaussian distribution. They are
expressed as mean values with standard deviation (SD).
Measurements for the number of fluorescent cells at the
level of the alveolar space (ACA count) didn’t show a
Gaussian distribution and are therefore expressed as me-
dian values and their interquartile range (IQR).
Mean LA for the consecutive procedures was 295.5 41 mm
and 292.7  32 mm respectively. Measurements showed a
linear correlation of 0.60 (pZ 0.001) (Fig. 5). ICC2.1 was 0.59
(95% CI 0.27e0.80) with a mean difference between mea-
surements of 2.6 mm (95% CI 63.4e68.6). A BlandeAltman
Figure 2 Flowchart representing the patient selection
procedure.
Table 1 Overview of the variables measured, intraclass corre
measurement. LA: long axis of the alveolar duct diameter, SA:
thickness of the alveolar duct diameter, mm : micrometer, A
fluorescence intensity, ACAD: alveolar cell diameter, ICC2.1: in
random effects, CI: confidence interval, SEM : standard error of
distributed were noted as mean values with standard deviation. D
with interquartile range.
Distribution 1st pCLE
procedure
2nd pCLE
procedure
I
(
LA (mm) Gaussian 295  41 293  32 0
SA (mm) Gaussian 224  32 228  31 0
SWT (mm) Gaussian 6  1 6  1 0
ACA count (n/field) Skewed 50(18e88) 34(17e50) 0
ACA AF (units) Gaussian 972  426 882  405 0
ACAD (mm) Gaussian 23  3 22  2 0
Morphometrics using pCLE of the respiratory tract 1237analysis is plotted in Fig. 6. Standarderror ofmeasurement for
LA was calculated at 23.5 mm (7.98%).
Mean SA for the consecutive procedures was 223.9 32 mm
and 228.3  31 mm respectively. Measurements showed a
linear correlationof 0.62 (pZ 0.0008) (Fig. 5). ICC2.1was 0.62
(95% CI 0.32e0.81) with a mean difference between mea-
surements of4.5 mm (95% CI 58.3e49.4). A BlandeAltman
analysis is plotted in Fig. 6. Standarderror ofmeasurement for
SA was calculated at 19.2 mm (8.5%).
Mean SWT for the consecutive procedures was
6.4  1.0 mm and 6.4  1.0 mm respectively. Measurements
showed a linear correlation of 0.55 (p Z 0.004) (Fig. 5).
ICC2.1 was 0.56 (95% CI 0.22e0.78) with a mean difference
between measurements of 0.07 mm (95% CI 1.85e1.99). A
BlandeAltman analysis is plotted in Fig. 6. Standard error of
measurement for SWT was calculated at 0.68 mm (10.6%).
Cellularity
Median ACA count for the consecutive procedures was 50
(interquartile range18e88)and34(interquartile range17e50)
respectively. Measurements showed a linear correlation of
0.81 (p < 0.001) (Fig. 5). ICC2.1 was 0.74 (95% CI 0.53e0.86)
with a mean difference betweenmeasurements of 4.3 (95% CI
50.1e58.7). A BlandeAltman analysis is plotted in Fig. 6.
Mean ACAD for the consecutive procedures was
22.75  3.6 mm and 21.94  2.8 mm respectively. Measure-
ments showed a linear correlation of 0.30 (Fig. 5). ICC2.1was
0.29 (95% CI 0.22e0.68) with a mean difference between
measurements of 0.80 mm (95% CI 6.8e8.4). A BlandeAlt-
man analysis is plotted in Fig. 6. Standard error of mea-
surement for ACAD was calculated at 2.72 mm (12.2%).
Autofluorescence
Mean ACA AF for the consecutive procedures was
971.8  426 units and 881.9  405 units respectively.
Measurements showed a linear correlation of 0.79
(p Z 0.0003) (Fig. 5). ICC2.1 was 0.78 (95% CI 0.48e0.92)
with a mean difference between measurements of 89.9
(95% CI 445.4e625.3). A BlandeAltman analysis is plotted
in Fig. 6. Standard error of measurement for ACA AF was
calculated at 193.07 units (20.8%).lation coefficients, mean differences and standard errors of
short axis of the alveolar duct diameter, SWT: septal wall
CA: autofluorescent cells in the alveolar space, AF: auto-
traclass correlation coefficients single measures, two way
measurement, N/A: not applicable., Data showing Gaussian
ata showing skewed distribution were noted as median values
CC2.1
95% CI)
Mean difference
(95% CI)
SEM
(SEM%)
.59(0.27e0.80) 2.6(63.4 to 68.6) 23.5 (8%)
.62(0.32e0.81) 4.5(58.3 to 49.4) 19.2 (8.5%)
.56(0.22e0.78) 0.1(1.85 to 1.99) 0.7 (10.6%)
.74(0.53e0.86) 4.3(50.1 to 58.7) N/A
.78(0.48e0.92) 89.9(445.4 to 625.3) 193.1 (20.8%)
.29(0.22 to 0.68) 0.8(6.8 to 8.4) 2.7 (12.2%)
Figure 3 Beforeeafter plot showing repeated measurements of (top left to bottom right) the long axis of the alveolar duct
diameter (LA), the short axis of the alveolar duct diameter (SA), the septal wall thickness of the alveolar duct (SWT), number of
fluorescent cells in the alveolar space (ACA) per microscopical field, autofluorescence intensity of alveolar cells (ACA aF) and the
diameter of the alveolar cells (ACAD).
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Our survey of testeretest reliability for pCLE imaging shows
that intraclass correlation coefficients for morphometrical
analysis are moderate. The morphometrical data studied
included long and short axis and thickness of elastic fibers
at alveolar openings situated at the level of the alveolar
duct. Values of intraclass correlation coefficients for
cellularity and alveolar cell autofluorescence show that the
consistency of these data between two consecutive pro-
cedures is excellent.Figure 4 Histogram representing the distribution of time
intervals between the two pCLE procedures for the 26 patients
included in the data analysis. Time intervals are presented on
the horizontal axis, the relative frequencies as percent on the
vertical axis.TesteRetest reliability is one of the measures available
to assess consistency for diagnostic tests as well as for
medical tools. Our test cases, i.e the lung transplant re-
cipients, were subjected twice to the same test of interest,
i.e pCLE imaging. The more measurement results obtained
during both procedures are equal, or if not equal the more
their difference attains zero, the more reliable the test
proves to be. A reliable test produces consistent results,
being one of the important factors for a high test accuracy.
The present study shows that consecutive measurements
of alveolar duct diameters and elastic fiber thickness,
categorized as endomicroscopic morphometry, obtain an
only moderate intraclass correlation between 0.55 and
0.62, although the mean differences between measure-
ments and the standard error of measurement (8e10% of
SD) are fair. The poor consistency of endomicroscopic
morphometry probably results from the fact that the
amount of alveolar space volume sampled is only a small
fraction of the entire lung volume and less representative
for the endomicroscopic aspect of the entire lung. More-
over, it is technically unfeasible to attain the exact same
acini in both procedures. Due to respiration movements and
compression of alveolar tissue by the tip of the flexible
probe, the dimensions of the alveolar ducts are changing
dynamically, resulting in anatomical distortion and hence
varying measurements. On the other hand, with relatively
few measurements representing only a small part of the
entire lung volume, correlations of about 0.60 could be
classified as ‘better than intuitively expected’. The selec-
tion of patients with clear chest CT imaging, however, leads
to an ‘ideal’ study population with rather homogeneous
lung parenchyma. The results of this analysis are therefore
not automatically applicable to pCLE imaging of diseased
Figure 5 Scatter plots for repeated measurements of (top left to bottom right) the long axis of the alveolar duct diameter (LA),
the short axis of the alveolar duct diameter (SA), the septal wall thickness of the alveolar duct (SWT), number of fluorescent cells in
the alveolar space (ACA) per microscopical field, autofluorescence intensity of alveolar cells (ACA AF) and the diameter of the
alveolar cells (ACAD). Correlation coefficients and their statistical significance are noted at the right side of the corresponding
graph.
Morphometrics using pCLE of the respiratory tract 1239lung tissue in which tissue heterogeneity will easily lead to
sample bias since only a small part of all acini can be
explored by the confocal probe.
Measurements for ACA count and ACA fluorescence show
good intraclass correlation with small mean differences be-
tween both procedures. BlandeAltman analysis shows that
testeretest reliability for ACA count is higher when smaller
amounts of alveolar cells are present. These findings couldFigure 6 BlandeAltmann plot for (top left to bottom right) the lo
alveolar duct diameter (SA), the septal wall thickness of the alveola
(ACA) per microscopical field, autofluorescence intensity of alveola
The broken line indicates the mean difference between two measu
agreement.reflect that measuring ACA count and fluorescence is less
dependent of the localization of the semiflexible probe and
may even suggest that once fluorescent cells are present
they tend to stay present and keep their autofluorescent
characteristics for a longer period (at least 3e6 months as
this is the mean interval between procedures in our trial).
Similar conclusions as to the duration of ACA auto-
fluorescence were made, based upon in vitro analysis ofng axis of the alveolar duct diameter (LA), the short axis of the
r duct (SWT), number of fluorescent cells in the alveolar space
r cells (ACA AF) and the diameter of the alveolar cells (ACAD).
rements or ‘bias’. The dotted lines represent the 95% limits of
1240 J. Yserbyt et al.macrophage autofluorescence in smoking subjects.7 In lung
transplant recipients, ACA seem to appear in non-smoking
subjects. Correlation analysis in our entire population
shows that the presence of ACA is not related to respiratory
infection, nor to any component of the immunosuppressive
drug regimen and certainly not to respiratory condition prior
to transplantation (e.g. cystic fibrosis). The exact reason for
the absence or appearance of these autofluorescent cells
during alveoloscopy remains to be clarified.
Findings for cell diameter show poor consistency between
consecutive procedures. These measurements are not corre-
lating at all between consecutive procedures, what could be
explainedby the fact that cells visualized in the alveolar space
show high heterogeneity in shape and dimensions. They
probably represent a mixture of cells, e/g macrophages,
neutrophils, epithelial cells, etc. There is however amoderate
correlation between ACA count and the macrophage count in
BAL fluid (Pearson r Z 0.51, p Z 0.004), that could confirm
earlier findings showing that theautofluorescent cells found in
the alveolar ducts are mainly macrophages.1
Obviously, there are some limitations to the study. For
our purpose, i.e assessing a novel imaging tool, the set-up
to obtain consecutive measurements of the same variables
in the same patients under the same conditions with the
same diagnostic tool, did not proof to be easy. Recruitment
took place among lung transplant recipients being
frequently referred for surveillance bronchoscopy. In these
patients we asked informed consent to have a pCLE pro-
cedure performed at time of the scheduled bronchoscopy.
On the one hand, one could state that using lung transplant
recipients instead of healthy volunteers could jeopardize
the consistency of our test results, although we tried to
exclude patients ‘not in stable clinical condition’ from the
analysis. On the other hand, all procedures were performed
at least 3 months and utmost 48 months after trans-
plantation, avoiding early postoperative pulmonary com-
plications as well as limiting the probability of ongoing
bronchiolitis obliterans syndrome.
Nevertheless, in our opinion this study could herald some
clinical relevance as to the diagnostic yield of pCLE imaging
throughout the respiratory tract. Since consistency of
morphometrical data is low due to sample bias, dynamical
changes in alveolar duct diameter and technical aspects,
firm conclusions cannot be drawn when structural changes
in the alveoloscopic characteristics of alveolar ducts are
observed. This doesn’t exclude that when considerable
destruction of alveolar parenchyma has taken place (e.g.
pulmonary fibrosis), certain abnormal morphologicalpatterns can be described. On the other hand, the
appearance of fluorescent alveolar cells or a considerable
change in their fluorescence intensity is more likely to be
useful information because of its high consistency. For the
further development of pCLE as a diagnostic tool, we
should study pulmonary diseases provoking a rise of these
two pCLE characteristics, e.g. COPD/emphysema in
actively smoking subjects.
In conclusion, probe-based confocal laser endomicro-
scopyenables imaging andquantitativemeasurements at the
level of small airways and alveolar ducts. Data consistency
and testeretest reliability are good for alveolar cellularity
and autofluorescence intensity of alveolar cells, parallel to
what has been found for the interobserver agreement.4 Data
consistency is only moderate for morphometric analysis.Conflicts of interest
No conflicts of interest. Financially supported by the Clin-
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